Seeing the World Through Assorted Glasses (SWAG)
Seeing the World Through Assorted Glasses (SWAG)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Good physical health
- Proficiency in written and spoken English
- Reported average total sleep time <9 hours (so nights spent in sleep lab will not result in sleep deprivation)
Exclusion Criteria:
- Taking regular medication affecting sleep and/or mood
- Travel across more than two time zones within the past month
- Smoke > 5 cigarettes per day
- Excessive caffeine use (>2 cups at one time or >500 mg daily)
- No current Axis I Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Disorder
- No current use of street drugs
- No history of sleep disorder/bipolar disorder/psychosis/seizure disorder/chronic medical condition
- Night shift work within the past 2 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
OTHER: Amber Lenses
Participants will be randomized to participate in the amber lens condition first or second.
Outcome measures to assess the effects of wearing amber lenses to block the blue light spectrum of light includes mood and sleep rating questionnaires (Positive and Negative Affect Scale, PANAS; Leeds Sleep Evaluation Questionnaire) as well as measuring the levels of melatonin the body is producing while wearing the glasses.
|
Glasses fitted with amber lenses that block the blue spectrum of light (~470 nm) to be worn prior to desired sleep onset time.
|
|
OTHER: Placebo Lenses
Participants will be randomized to participate in the placebo lens condition first or second.
Outcome measures to assess the effects of wearing placebo lenses to allow all spectrums of light includes mood and sleep rating questionnaires (Positive and Negative Affect Scale, PANAS; Leeds Sleep Evaluation Questionnaire) as well as measuring the levels of melatonin the body is producing while wearing the glasses.
|
Glasses fitted with placebo lenses that allow all visible spectrum of light to be worn prior to desired sleep onset time.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Increase dim-light melatonin production
Time Frame: 4 days
|
Hourly saliva samples will be collected from participants at the end of each 4 night interval in order to measure levels of melatonin production.
|
4 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improved subjective self-reported mood
Time Frame: 4 days
|
Participants will complete the Positive and Negative Affect Scale (PANAS) on a daily basis to measure self-reported mood.
|
4 days
|
|
Improved objective measures of sleep
Time Frame: 4 days
|
Participants will complete nights in the sleep lab while wearing a watch device to measure arterial tone in order to objectively measure time spent in different sleep stages.
|
4 days
|
|
Improved subjective self-reported sleep quality
Time Frame: 4 days
|
Participants will complete the Leeds Sleep Evaluation in order to assess self-report of sleep quality.
|
4 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Eric Youngstrom, PhD, University of North Carolina, Chapel Hill
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 15-0389
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.